These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24668309)

  • 1. Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats.
    Khajuria DK; Razdan R; Mahapatra DR
    J Orthop Sci; 2014 Jul; 19(4):646-56. PubMed ID: 24668309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats.
    Khajuria DK; Razdan R; Mahapatra DR
    Rev Bras Reumatol; 2015; 55(2):103-12. PubMed ID: 25582996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Additive effect of zoledronic acid and alfacalcidol in the treatment of disuse osteoporosis in rats].
    Khajuria DK; Disha C; Razdan R; Mahapatra DR
    Rev Bras Reumatol; 2015; 55(3):240-50. PubMed ID: 25440697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model.
    Khajuria DK; Razdan R; Mahapatra DR
    Eur J Pharm Sci; 2015 Jan; 66():173-83. PubMed ID: 25444840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.
    Shiraishi A; Miyabe S; Nakano T; Umakoshi Y; Ito M; Mihara M
    BMC Musculoskelet Disord; 2009 Jun; 10():66. PubMed ID: 19527501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotective effect of propranolol in ovariectomized rats: a comparison with zoledronic acid and alfacalcidol.
    Khajuria DK; Razdan R; Mahapatra DR; Bhat MR
    J Orthop Sci; 2013 Sep; 18(5):832-42. PubMed ID: 23835529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of early and late zoledronic acid administration on vertebral structure and strength in ovariectomized rats.
    Brouwers JE; van Rietbergen B; Bouxsein ML
    Calcif Tissue Int; 2008 Sep; 83(3):186-91. PubMed ID: 18712432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
    Sugimoto M; Futaki N; Harada M; Kaku S
    Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
    J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination therapy with zoledronic Acid and propranolol improves the trabecular microarchitecture and mechanical property in an rat model of postmenopausal osteoporosis.
    Khajuria DK; Razdan R; Mahapatra DR
    J Osteoporos; 2014; 2014():586431. PubMed ID: 24800099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    Exp Anim; 2006 Jul; 55(4):333-42. PubMed ID: 16880680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats.
    Dikicier E; Karaçaylı Ü; Dikicier S; Günaydın Y
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1106-11. PubMed ID: 24530079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined treatment with zoledronic acid and propranolol on mechanical strength in an rat model of disuse osteoporosis.
    Khajuria DK; Razdan R; Mahapatra DR
    Rev Bras Reumatol; 2015; 55(6):501-11. PubMed ID: 25480532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: In vitro and pharmacodynamic evaluation.
    Khajuria DK; Vasireddi R; Trebbin M; Karasik D; Razdan R
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():698-708. PubMed ID: 27987763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats.
    Chen B; Li Y; Yang X; Xu H; Xie D
    Osteoporos Int; 2013 Jul; 24(7):2115-21. PubMed ID: 23389695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study.
    Iwamoto J; Seki A; Sato Y
    Bone; 2014 Jul; 64():88-94. PubMed ID: 24727162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.